Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve ....
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anlon Healthcare Limited has informed the stock exchanges that a meeting of its Board of Directors is scheduled for Monday, February 9, 2026, at its registered office in Rajkot, Gujarat. The main agenda item is to consider and approve the Unaudited Standalone Financial Results along with the Limited Review Report by the Auditor for the quarter and nine months ended December 31, 2025 (Q3FY26 and 9MFY26). The filing is made in compliance with SEBI LODR Regulations 29 and 33. No specific financial numbers, projections, or business updates are disclosed in this intimation.
This is a routine pre-results intimation and does not by itself move the stock. Investors should watch for the actual Q3FY26 results announcement on or after February 9, 2026, for revenue, profit, and margin trends. A sharp deviation from street expectations on the results day could trigger a price reaction.